SMYD4 may act as an inhibitor of certain transcription factors to regulate the expression of platelet-derived growth factor receptor A (PDGFR-A), thereby inhibiting the proliferation and survival of BC cells (Hu et al., 2009). The gene discussed is SMYD4; the disease is breast cancer.